DNLI
Denali Therapeutics Inc. Common Stock#11 · 2020EPA+Yearly return
+411%
Peak return
+473%
Max drawdown
-59%
ADR (20 days)
+6.5%
Base
14 days / -23.0%
Prior run
+85%
Breakout volume
15.2x
Pivot
$29.05
Catalyst Unternehmensmeldung2020-01-148-K Sonstiges Ereignis (Item 8.01), Denali Therapeutics Inc.SEC EDGAR
Offizielle Unternehmensmitteilung im Umfeld des Ausbruchs. Beleg: offizielles 8-K-Filing bei der SEC.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare DNLI with the current market directly.